Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/BBIO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BridgeBio Pharma Inc (BBIO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BridgeBio Pharma (BBIO) trades at $74.76, down 0.11% with a bearish technical signal despite strong analyst support. The company shows explosive revenue growth from $9M in 2023 to $502M in 2025, though it remains deeply unprofitable with a -144.4% net margin. Recent news highlights successful drug launches and pipeline progress, including acoramidis showing disease reversal potential in cardiac patients and three potential product launches by mid-2027.
While BBIO faces significant execution risks and cash burn, Wall Street maintains strong bullish sentiment with 89% buy ratings and a $106.82 price target representing 43% upside. The investment thesis hinges on successful commercialization of its rare disease pipeline, but shareholders must tolerate substantial volatility and continued losses during this growth phase.
Read full analysis

Key Stats

  • Market Cap
    $14.62B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $90.17
  • 52W Low
    $49.00
  • Typical Hold Time
    -
  • Enterprise Value
    $16.39B
  • Div Yield
    -
  • Trading Activity
    -
$74.84
52W Low: $49
25 Sep 2025
52W High: $90.17
09 Jul 2026

Track BridgeBio Pharma Inc (BBIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BridgeBio Pharma Inc has traded between a low of $49 and a high of $90.17, highlighting its annual price range. Buy and sell BridgeBio Pharma Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Most Recent News

Content is generated by Aura AI

Novartis shares plunge 12.5% after two Phase 3 drug trials fail primary goals

Novartis shares dropped over 12.5% after its Phase 3 HARBOR trial for del-desiran and Phase 3 HORIZON trial for pelacarsen both failed to meet primary endpoints. These failures mean the drugs did not show significant benefits over placebo for their t...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
Novartis shares plunge 12.5% after two Phase 3 drug trials fail primary goals

Levi & Korsinsky probes lululemon over tariff refund disclosures after earnings and guidance cuts.

Levi & Korsinsky is investigating lululemon athletica for potentially misleading disclosures about a $134.5 million federal tariff refund included in its recent quarterly earnings. The refund boosted earnings per share by $0.86 and operating margins,...

Market News
4 hours ago
PRNewsWire
Bearish
news icon
Levi & Korsinsky probes lululemon over tariff refund disclosures after earnings and guidance cuts.

Structure Therapeutics shows strong obesity drug results, remains a strong buy with $1.3B cash runway.

Structure Therapeutics reported promising 72-week data for its oral obesity drug aleniglipron, showing 16.2% weight loss with low adverse event discontinuations and no liver injury. The company also advanced ACCG-2671, an oral amylin agonist with hum...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
Structure Therapeutics shows strong obesity drug results, remains a strong buy with $1.3B cash runway.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $14.62B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $90.17
  • 52W Low
    $49.00
  • Typical Hold Time
    -
  • Enterprise Value
    $16.39B
  • Div Yield
    -
  • Trading Activity
    -
$74.84
52W Low: $49
25 Sep 2025
52W High: $90.17
09 Jul 2026

Track BridgeBio Pharma Inc (BBIO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BridgeBio Pharma Inc has traded between a low of $49 and a high of $90.17, highlighting its annual price range. Buy and sell BridgeBio Pharma Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!